ZGN-1061

ZGN-1061 · Zafgen, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ZGN-1061, covering 2019-05-24 to 2019-05-24. Get the full timeline:

Most recent: Clinical Trial Update: Study to Assess the Effects and Safety of ZGN-1061 in Overweight and Obese Participants With Type 2 Diabetes [Phase 2]

See pricing